UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

Current Report Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): August 1, 2013

 

ROCHESTER MEDICAL CORPORATION

(Exact name of registrant as specified in its charter)

 

Minnesota

 

0-18933

 

41-1613227

(State or other jurisdiction
of incorporation)

 

(Commission file number)

 

(I.R.S. Employer
Identification No.)

 

One Rochester Medical Drive, Stewartville, MN 55976

(Address of principal executive offices)

 

Registrant’s telephone number, including area code:  (507) 533-9600

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 



 

Item 7.01.                                        Regulation FD Disclosure.

 

The following information is being “furnished” in accordance with General Instruction B.2 of Form 8-K and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

 

Furnished herewith as Exhibit 99.1 and incorporated by reference herein is a copy of presentation materials prepared by Rochester Medical Corporation for use at investor conferences.

 

Item 9.01.                                        Financial Statements and Exhibits.

 

(d) Exhibits.

 

Reference is made to the Exhibit Index hereto with respect to the exhibits furnished herewith.  The exhibits listed in the Exhibit Index hereto are being “furnished” in accordance with General Instruction B.2 of Form 8-K and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

 

2



 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

 

Date:                  August 1, 2013

 

 

ROCHESTER MEDICAL CORPORATION

 

 

 

 

 

By:

/s/ David A. Jonas

 

 

David A. Jonas

 

 

Chief Financial Officer

 

3



 

EXHIBIT INDEX

 

Exhibit No.

 

Description

 

 

 

  99.1

 

Presentation materials prepared by Rochester Medical Corporation

 

4


Rochester Medical Corp. (MM) (NASDAQ:ROCM)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more Rochester Medical Corp. (MM) Charts.
Rochester Medical Corp. (MM) (NASDAQ:ROCM)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more Rochester Medical Corp. (MM) Charts.